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Abstract: Novel multifunctional reagents were applied in
combination with a lipid probe for affinity enrichment of
myristoylated proteins and direct detection of lipid-modified
tryptic peptides by mass spectrometry. This method enables
high-confidence identification of the myristoylated proteome
on an unprecedented scale in cell culture, and allowed the first
quantitative analysis of dynamic changes in protein lipidation
during vertebrate embryonic development.
Although advancements in protein mass spectrometry (MS)
have enabled global profiling of numerous post-translational
modifications (PTMs), confident high-throughput identifica-
tion of lipidated proteins remains problematic. Lipidation
adversely affects solubility, chromatographic properties, and
ionization of modified peptides, and routine proteome-wide
detection by MS and assignment of the modification sites
remains an unsolved challenge.[1] Furthermore, lipidated
proteins are often present at relatively low abundance in
cells, and lipid-specific enrichment is required to reduce
sample complexity and improve discovery. Enrichment strat-
egies can exploit natural features of the lipid, for example, the
use of anti-farnesylpeptide antibodies;[2] indirect analysis
through acyl–biotin exchange for S-acylation;[3] or more
generalizable introduction of a functional handle through
metabolic incorporation of a bioorthogonal chemical tag.[4]
Co-translational myristoylation is a specific class of
protein lipidation whereby N-myristoyl transferases (NMTs)
catalyze the covalent and irreversible addition of a tetradeca-
noyl chain at an N-terminal glycine (Gly), revealed by the
action of methionine aminopeptidases during protein syn-
thesis at ribosomes.[5] Metabolic tagging has become the
technique of choice for whole-proteome profiling of the
cellular myristoylated proteome. As previously demon-
strated,[6] metabolic tagging of a cellular proteome with
tetradec-13-ynoic acid (YnMyr) and subsequent elaboration
through ligation with secondary reporters (capture reagents)
enables visualization, enrichment, and MS-based identifica-
tion of myristoylated proteins. This chemoproteomic method-
ology delivers greatly improved processing time and sensi-
tivity over traditional radioisotope or direct MS approaches,
but there are also limitations. Firstly, as with any affinity
enrichment technique, unspecific protein background is often
observed when coupled to high-sensitivity MS detec-
tion. Secondly, protein fatty acyl transferases that utilize
longer acyl-CoAs as substrates may also use YnMyr either
natively or following chain extension, which may lead to
false positive identifications.[7] Finally, robust and general
methods for confirmation of the lipidation site have yet to be
established.
To overcome these limitations, we report a portfolio of
reagents for the enrichment and visualization of myristoy-
lated proteomes and direct MS detection of lipid modification
of protein N termini. The design of these reagents is based on
compound 1 (Figure 1a), a robust tool for enrichment and in-
gel fluorescence (igFl) analysis of metabolically tagged
proteomes.[8] To make 1 amenable to the detection of lipid-
modified peptides, we envisioned the introduction of a linker
(Figure S1 in the Supporting Information) to facilitate
cleavage as an integral part of a proteomic workflow. In
a standard tagging experiment (Figure 1b), cells or organisms
are treated with YnMyr or a myristic acid (Myr) control to
metabolically tag proteins via activation by cellular acyl-CoA
synthase followed by transfer by NMTs. The cells/organisms
are harvested and the metabolically tagged proteins ligated to
a capture reagent through copper-catalyzed alkyne azide
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cycloaddition (CuAAC) and affinity-enriched. The enriched
proteomes are visualized by igFl to assess metabolic tagging
and enrichment efficiency, or analyzed through on-bead
proteolytic digestion, MS analysis, and software-aided protein
identification.
We synthesized a library of reagents bearing enzymati-
cally cleavable linkers (Figure 1a, Table S1 in the Supporting
Information). Reagents 2–5
contain arginine (Arg) resi-
dues and reagent 6 contains
a lysine (Lys) residue to
enable proteolysis by tryp-
sin and simultaneous en-
hancement of
the ionization properties of
lipidated peptides. Reagent
7 in turn incorporates phe-
nylalanine (Phe) and
reagents 8–9 incorporate
aspartic acid (Asp) to facil-
itate cleavage by chymo-
trypsin and AspN, respec-
tively. These proteases are
less commonly used in pro-
teomic workflows, however
they may offer complemen-
tary protein sequence cov-
erage, thus improving over-
all modified peptide discov-
ery. Similarly to 1, com-
pounds 2 and 6 were
equipped with the
TAMRA fluorophore (R1)
for fast visualization by igFl.
All other reagents lack the
fluorophore to reduce bulk
and possible steric hin-
drance, since biotin (con-
tained in R2) is sufficient
for visualization (e.g., by
using streptavidin conju-
gated to horseradish perox-
idase (streptavidin–HRP)).
In addition, 5 was equipped
with a-azido-arginine to fur-
ther minimize
the size of the cleaved prod-
uct. Finally, we aimed to
enhance the ionization
properties of the lipidated
peptides still further by
incorporating trimethyl (4,
7, 8) or dimethyl (9) lysine
residues.
Taking advantage of
both the TAMRA and
biotin moieties, we first
investigated the efficiency
of 2–9 for the capture and
enrichment of myristoylated proteins. HEK293 cells were
treated with YnMyr orMyr for 24 h followed by lysis, CuAAC
with 1–9, and affinity enrichment on streptavidin-conjugated
beads. Captured proteins were eluted by thermal denatura-
tion, resolved by SDS-PAGE, and visualized by igFl or
Western Blotting with streptavidin–HRP (Figure S2a and b).
We were pleased to observe that the majority of the reagents
Figure 1. a) Structures of capture reagents 1–9. Protease (trypsin, chymotrypsin, AspN) cleavage sites are
indicated by arrows. b) General proteomic workflow; the capture reagent is shown schematically as a cartoon:
star=TAMRA (R1), fused pentagons=biotin (R2).
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showed comparable enrichment efficiency to 1 and that there
was negligible background signal, as shown by the Myr
control. However, the performance of 8 and 9 was clearly
diminished, which may indicate lower efficiency of CuAAC,
and these reagents were excluded from further analysis. We
also observed that despite their bulkier structures, 2 and 6
performed as robustly as 1, which was demonstrated by two
alternative readouts.
We then evaluated the capacity of these
reagents to identify proteins with a consen-
sus myristoylation sequence (MG-pro-
teins) and, most importantly, N-terminally
myristoylated peptides. Samples were pre-
pared as described above, subjected to
CuAAC with 2–7, affinity-enriched, and
digested with either trypsin (2–6) or chy-
motrypsin (7), followed by MS analysis.
Five reagents (2–4 and 6–7) identified
38 lipid-modified peptides with high
(> 99%) confidence (Figure S2c and
Table S2 in the Supporting Information).
Nearly 90% of these peptides were discov-
ered with 2, thus demonstrating its high
effectiveness despite the presence of the
TAMRA dye and lower predicted net
charge compared to 3 and 4, respectively.
Reagent 2 was also superior to 6, thus
suggesting that the proteolysis step and/or
the ionization properties of the Arg-con-
taining conjugates were improved com-
pared to Lys since CuAAC and enrichment
were similar (Figure S2). These steps also
seemed efficient for 5, however, no lipi-
dated peptides were detected; we speculate
that proximity of the triazole to the cleav-
age site reduces the affinity for trypsin.
Regardless of the reagent type, approxi-
mately 30% of all of the proteins identified
carried an N-terminal MG motif
(Table S3), which is more than four-fold
higher than in analysis of the native
proteome, where the abundance of MG
proteins is approximately 7%.[9] The
remaining 70% of the detected proteins
represent tagging at sites other than the N terminus as a result
of the promiscuity of lipid transferases and proteins binding to
beads and/or tagged proteins, thus highlighting the utility of
methodologies that allow either quantification of NMT
inhibition (if reliable inhibitors are available)[6b] or direct
detection of lipidated peptides to improve modified protein
ID confidence.
Having selected the best performing capture reagent (2),
we next aimed to maximize the discovery of myristoylated
peptides and the corresponding endogenous protein sub-
strates of human NMT. Larger-scale chemical proteomics
experiments were undertaken with three commonly used cell
lines: HeLa, MCF7, and HEK293. Two complementary
software packages were employed for MS data analysis,
with primary identification of lipid-modified peptides per-
formed with PEAKS7, and MaxQuant1.5 used as a secondary
platform.[10] The latter was also used to quantify protein levels
between YnMyr- and Myr-treated samples, with Myr serving
as a control for both nonspecific protein identification and
reliability of the modified peptide identifications. 81 lipid-
modified peptides were detected in PEAKS7 analysis, of
which approximately 40%were common to all three cell lines
(Figure 2a). MaxQuant analysis delivered 62 lipidated pep-
tides, four of which were not observed in PEAKS7.[11]
Importantly, each search engine returned only one lipidated
peptide common to both YnMyr and Myr control samples,
which was assigned as a false positive and excluded from the
list of myristoylated peptides (Table S4).
Based on statistically significant enrichment of MG
proteins pulled down from YnMyr-treated samples compared
to Myr controls, we identified 170, 163, and 145 candidate
myristoylated proteins for HEK293, HeLa, and MCF7 cells,
respectively (Table S5). However, a previous comprehensive
study of quantitative dose response to NMT inhibition
showed that enrichment is only a simple and indirect measure
of N-terminal myristoylation since only 70 out of 169 enriched
MG HeLa proteins robustly responded to NMT inhibition.[6b]
In agreement with this alternative approach, our dataset
Figure 2. a) Modified peptide discovery in human cells. b) Time-dependent metabolic
tagging with YnMyr visualized by igFl. c) Quantitative MS-based analysis of myristoylation in
developing zebrafish embryos. Color coding represents normalized levels (log2 scale) of
myristoylation. Protein targets are reported by gene names with peptide indicated as (+).
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shows direct evidence for 87 of the candidate proteins in the
three cell lines. Herein, we provide direct proof for myris-
toylation in Hela cells for 47 previously reported proteins, as
well as significantly increased coverage of since direct MS/MS
evidence for myristoylated peptides was detected for 69
enrichedMG targets in HeLa, 65 in HEK293, and 50 inMCF7
cells (Table S5). This represents the largest directly validated
database reported to date for the N-myristoylated human
proteome.
We next applied 2 to profile the myristoylated proteome
for the first time in a developing organism. Following
evaluation of YnMyr tagging specificity (Figure S3), Danio
rerio (zebrafish) embryos were metabolically tagged in
specific time windows (0–24, 48–72, and 96–120 hours post-
fertilization (hpf)) and processed according to the standard
workflow. Chemical proteomics experiments revealed the
scope of myristoylation in developing zebrafish; 72 potential
myristoylation targets were identified based on statistical
analyses of YnMyr/Myr enrichment and 56 lipid-modified
peptides were discovered (Tables S6 and S7). Notably, in the
absence of validated NMT inhibitors for zebrafish, the
methodology presented herein is currently the only approach
for confident assignment of myristoylated proteins in this
animal model.
We also investigated the dynamic nature of myristoylation
through pulsed YnMyr tagging as described above, coupled
with visualization by igFl and quantification through triplex
dimethyl labeling[12] (Figure 2b and c, respectively). IgFl
analysis indicates development-stage-specificD. rerio protein
myristoylation profiles that reflect differential protein expres-
sion during embryonic development. Further MS-based
analysis allowed the quantification of myristoylation dynam-
ics for 54 zebrafish proteins (Figure 2c), which revealed that
myristoylation is most prominent in early development.
Several proteins myristoylated within 24 hpf (e.g., prkaca
and gnai families) participate in progesterone-mediated
maturation, the hedgehog and wnt signaling pathways,
melanogenesis, and meiosis, all of which are critical in early
development (Table S8).
In summary, the multifunctional capture reagents
reported herein enable robust identification of metabol-
ically-tagged myristoylated proteomes, with unprecedented
confidence resulting from the combination of chemical-
probe-based enrichment and release and direct detection of
lipid-modified peptides by MS. Previously reported
reagents[13] typically required an extra proteolytic step and
their capacity to enable the detection of lipidated peptides has
not been demonstrated. Herein, we report the largest data-
base (87 counts) of experimentally validated human proteins
that are myristoylated at an endogenous level in living cells.
We also present the first profile of myristoylation in a living
multicellular organism and the confident identification of
over 50 novel targets. Importantly, this work provides the first
example of the analysis of any protein lipidation event during
vertebrate development. We envision that our reagents will
find application in the quantitative and dynamic analysis of
other PTMs, and in related workflows such as activity-based
protein profiling, both in cells and in multicellular organisms.
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